Department of Pulmonary Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
J Pain Symptom Manage. 2020 Nov;60(5):933-940. doi: 10.1016/j.jpainsymman.2020.06.012. Epub 2020 Jun 20.
Although idiopathic pulmonary fibrosis (IPF) has worse outcomes compared with most malignancies, patients with IPF receive poor access to optimal palliative care.
This study aimed to characterize the practice of pulmonologists regarding palliative care and end-of-life communication for patients with IPF and identify perceived difficulties and barriers thereto.
Self-administered questionnaires were sent by mail to representative pulmonologists from Shizuoka prefecture, Japan. Physician-reported practice, difficulties, timing of end-of-life communication, and barriers related to palliative care were investigated.
Among the 135 participants, 130 (96%) completed the questionnaire. Most of the participants reported that patients with IPF complained of dyspnea and cough. However, less morphine was prescribed for IPF than for lung cancer. The participants experienced greater difficulty in providing palliative care for IPF than for lung cancer. Moreover, actual end-of-life discussions in patients with IPF were conducted later than the physician-perceived ideal timing. Among the barriers identified, few established treatment and difficulty in predicting prognosis (odds ratio [OR] 2.0; P = 0.04), discrepancies in understanding and care goals among patients, family, and medical staff (OR 2.2; P = 0.03), and inadequate communication about goal of care (OR 2.3; P = 0.003) were significantly associated with the physician-perceived difficulties in providing palliative care for patients with IPF.
Pulmonologists experienced greater difficulty in providing palliative care to patients with IPF than to those with lung cancer. Clinical studies on the optimal palliative care for patients with IPF are urgently required.
与大多数恶性肿瘤相比,特发性肺纤维化(IPF)的预后更差,但 IPF 患者获得最佳姑息治疗的机会较少。
本研究旨在描述肺科医生对 IPF 患者姑息治疗和临终沟通的实践情况,并确定其面临的困难和障碍。
通过邮件向日本静冈县的代表性肺科医生发送了自我管理问卷。调查了医生报告的实践、困难、临终沟通的时间以及与姑息治疗相关的障碍。
在 135 名参与者中,有 130 名(96%)完成了问卷。大多数参与者报告称,IPF 患者抱怨呼吸困难和咳嗽。然而,IPF 的吗啡处方量低于肺癌。与肺癌相比,参与者在为 IPF 患者提供姑息治疗方面遇到了更大的困难。此外,与医生认为的理想时间相比,IPF 患者的实际临终讨论时间较晚。在确定的障碍中,治疗方案尚未确定和难以预测预后(比值比 [OR] 2.0;P = 0.04)、患者、家属和医务人员之间对治疗目标的理解和关怀目标存在差异(OR 2.2;P = 0.03)以及对治疗目标的沟通不足(OR 2.3;P = 0.003)与医生认为为 IPF 患者提供姑息治疗的困难显著相关。
与肺癌患者相比,肺科医生在为 IPF 患者提供姑息治疗方面遇到了更大的困难。迫切需要对 IPF 患者的最佳姑息治疗进行临床研究。